CERO Share Price Performance
US$0.075
-119.92 (-99.94%)
Price US$0.075
Share Pricen/a
CERo Therapeutics Holdings, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
CERO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
CERo Therapeutics Holdings, Inc. Key Details
About CERO
- Founded
- 2021
- Employees
- 8
- CEO
- WebsiteView website
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
